MM
MedMira Inc.
MMIRF · OTC
$0.04 +156.25% (+$0.03)
1M +6.67%
Market Cap $39.1M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.06
46.3% upside
Current Price
$0.041
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MMIRF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/S 105.47x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Rev. growth 36.79%
EPS growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Gross margin 64.42%
FCF margin 282.53%
Net margin 730.36%
Quality
59 /100
Average ROIC 27.44%
Asset turnover 0.11x
ROA 79.60%
Debt
0 /100
High Current ratio 0.06x
Int. coverage -2.08x
Debt/Equity N/A
Stability
63 /100
Moderate Beta 0.76x
Profitable years 0
Rev. volatility 25.94%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MMIRF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Hermes Chan
Employees
52
Headquarters
Halifax